Zoetis Inc. (0M3Q.L)

USD 169.5

(-0.56%)

Long Term Debt Summary of Zoetis Inc.

  • Zoetis Inc.'s latest annual long term debt in 2023 was 6.56 Billion USD , down -2.58% from previous year.
  • Zoetis Inc.'s latest quarterly long term debt in 2024 Q2 was 6.56 Billion USD , up 0.02% from previous quarter.
  • Zoetis Inc. reported annual long term debt of 6.73 Billion USD in 2022, down -0.07% from previous year.
  • Zoetis Inc. reported annual long term debt of 6.74 Billion USD in 2021, down -0.22% from previous year.
  • Zoetis Inc. reported quarterly long term debt of 6.56 Billion USD for 2024 Q2, up 0.02% from previous quarter.
  • Zoetis Inc. reported quarterly long term debt of 6.56 Billion USD for 2024 Q1, down -0.03% from previous quarter.

Annual Long Term Debt Chart of Zoetis Inc. (2023 - 2010)

Historical Annual Long Term Debt of Zoetis Inc. (2023 - 2010)

Year Long Term Debt Long Term Debt Growth
2023 6.56 Billion USD -2.58%
2022 6.73 Billion USD -0.07%
2021 6.74 Billion USD -0.22%
2020 6.75 Billion USD 10.59%
2019 6.11 Billion USD -5.15%
2018 6.44 Billion USD 30.08%
2017 4.95 Billion USD 10.85%
2016 4.46 Billion USD 0.11%
2015 4.46 Billion USD 22.51%
2014 3.64 Billion USD 0.03%
2013 3.64 Billion USD 615.52%
2012 509 Million USD -11.48%
2011 575 Million USD -14.56%
2010 673 Million USD 0.0%

Peer Long Term Debt Comparison of Zoetis Inc.

Name Long Term Debt Long Term Debt Difference
Editas Medicine, Inc. 24.37 Million USD -26832.546%
Dynavax Technologies Corporation 252.41 Million USD -2500.448%
Supernus Pharmaceuticals, Inc. 33.19 Million USD -19673.467%
Perrigo Company plc 3.63 Billion USD -80.687%
Illumina, Inc. 1.48 Billion USD -340.833%
Thermo Fisher Scientific Inc. 31.3 Billion USD 79.034%
Iovance Biotherapeutics, Inc. 1 Million USD -656300.0%
Walgreens Boots Alliance, Inc. 8.04 Billion USD 18.399%
IQVIA Holdings Inc. 12.95 Billion USD 49.332%
Heron Therapeutics, Inc. 173.75 Million USD -3677.776%
Regeneron Pharmaceuticals, Inc. 2.7 Billion USD -142.85%
Unity Biotechnology, Inc. 23.53 Million USD -27785.637%
Waters Corporation 2.3 Billion USD -184.709%
Biogen Inc. 7.18 Billion USD 8.684%
Sangamo Therapeutics, Inc. 33.51 Million USD -19485.26%
Evolus, Inc. 120.35 Million USD -5353.684%
Adicet Bio, Inc. 17.7 Million USD -36978.461%
Cara Therapeutics, Inc. 37.07 Million USD -17602.743%
bluebird bio, Inc. 224.41 Million USD -2824.886%
Esperion Therapeutics, Inc. 501.54 Million USD -1208.753%
FibroGen, Inc. 89.69 Million USD -7217.971%
Agilent Technologies, Inc. 2.73 Billion USD -140.0%
Corbus Pharmaceuticals Holdings, Inc. 3.23 Million USD -202578.23%
Homology Medicines, Inc. 43.17 Million USD -15102.89%
Geron Corporation 35.05 Million USD -18626.998%
Alnylam Pharmaceuticals, Inc. 2.34 Billion USD -180.151%
Amicus Therapeutics, Inc. 387.85 Million USD -1592.372%
Myriad Genetics, Inc. 130.9 Million USD -4914.515%
Viking Therapeutics, Inc. 936 Thousand USD -701182.051%
Intellia Therapeutics, Inc. 96.74 Million USD -6684.707%
Abeona Therapeutics Inc. 4.4 Million USD -149014.039%
Mettler-Toledo International Inc. 1.97 Billion USD -232.262%
BioMarin Pharmaceutical Inc. 593.09 Million USD -1006.737%
Vertex Pharmaceuticals Incorporated 724.7 Million USD -805.754%
Kala Pharmaceuticals, Inc. 34.19 Million USD -19098.596%
Ionis Pharmaceuticals, Inc. 1.4 Billion USD -368.731%
Atara Biotherapeutics, Inc. 45.69 Million USD -14265.439%
Verastem, Inc. 40.08 Million USD -16274.794%
Nektar Therapeutics 112.62 Million USD -5728.191%
Axsome Therapeutics, Inc. 178.07 Million USD -3586.191%
Aclaris Therapeutics, Inc. 3.07 Million USD -213432.856%
Sarepta Therapeutics, Inc. 1.13 Billion USD -479.595%
OPKO Health, Inc. 222.03 Million USD -2856.304%
Exelixis, Inc. 189.94 Million USD -3355.755%
Neurocrine Biosciences, Inc. 258.3 Million USD -2441.231%
Corcept Therapeutics Incorporated - USD -Infinity%
Anavex Life Sciences Corp. - USD -Infinity%
uniQure N.V. 130.06 Million USD -4946.707%
Imunon, Inc. 1.13 Million USD -576046.786%
Blueprint Medicines Corporation 610.96 Million USD -974.371%
Insmed Incorporated 1.19 Billion USD -450.047%
Halozyme Therapeutics, Inc. 1.49 Billion USD -337.819%
Agios Pharmaceuticals, Inc. 56.98 Million USD -11418.214%
TG Therapeutics, Inc. 100.11 Million USD -6456.264%
Incyte Corporation 29.16 Million USD -22408.744%
Emergent BioSolutions Inc. 446.5 Million USD -1370.101%